Literature DB >> 2714579

Biliary excretion of iron and ferritin in idiopathic hemochromatosis.

R Hultcrantz1, B Angelin, E Björn-Rasmussen, S Ewerth, K Einarsson.   

Abstract

The role of biliary excretion of iron and ferritin in iron overload was studied and evaluated. Ten patients with idiopathic hemochromatosis and two groups of controls (14 gallstone patients and 16 healthy subjects) were included. Liver tissue (obtained by percutaneous or operative biopsy) was investigated with light microscopy and transmission electron microscopy in combination with x-ray microanalysis. Fasting bile samples were obtained through duodenal aspiration or at cholecystectomy. Iron was determined in liver tissue and bile using atomic absorption spectroscopy, and ferritin was determined in serum and bile with a radioimmunoassay technique. All patients with hemochromatosis had iron-positive staining as seen in light microscopy. Electron microscopy showed iron-containing proteins in the lysosomes and cytosol of liver parenchymal cells, and this observation was supported by x-ray microanalysis. Hepatic iron concentration was increased about eightfold in the patients with hemochromatosis (p less than 0.001). Biliary iron concentration, expressed per millimole of bile acid, was increased about twofold (p less than 0.05) and biliary ferritin concentration about fivefold (p less than 0.001) in hemochromatosis. Four of the patients with hemochromatosis were reexamined after completed treatment with venesection; this resulted in normalized biliary concentrations of iron and ferritin. We conclude that biliary secretion of ferritin occurs in humans and that both iron and ferritin excretion are enhanced in hepatic iron overload. The apparently limited capacity of biliary iron excretion may be of importance for the hepatic iron accumulation in hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714579     DOI: 10.1016/0016-5085(89)90524-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.

Authors:  L Berglund; B Angelin; R Hultcrantz; K Einarsson; L Emtestam; G Drummond; A Kappas
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 3.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

4.  Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload.

Authors:  B M Myers; F G Prendergast; R Holman; S M Kuntz; N F LaRusso
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

5.  Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess.

Authors:  Courtney J Mercadante; Milankumar Prajapati; Jignesh H Parmar; Heather L Conboy; Miriam E Dash; Michael A Pettiglio; Carolina Herrera; Julia T Bu; Edward G Stopa; Pedro Mendes; Thomas B Bartnikas
Journal:  Haematologica       Date:  2018-11-08       Impact factor: 9.941

6.  Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron.

Authors:  Francesca La Carpia; Boguslaw S Wojczyk; Medini K Annavajhala; Abdelhadi Rebbaa; Rachel Culp-Hill; Angelo D'Alessandro; Daniel E Freedberg; Anne-Catrin Uhlemann; Eldad A Hod
Journal:  NPJ Biofilms Microbiomes       Date:  2019-09-24       Impact factor: 7.290

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.